LQDA (Liquidia) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Liquidia (LQDA)

The prospects for Liquidia Corporation (LQDA) rely on the commercial success of Yutreqsa and the outcome of patent litigation. The company's 12-month forward P/E clearly demonstrates capital dynamics, with the metric standing at 14.70. Business development is based on a strategic partnership in drug delivery, while its image as a bold innovator attracts investors who believe in the disruptive potential of the brand's technologies.

liquidia.com - Rasio kapitalisasi marang bathi mangsa ngarep LQDA (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis liquidia.com (LQDA)

Pambiji fundamental:LQDA Liquidia Technologies
Produk merek Liquidia Corporation

Forward P/E measures market expectations for capitalization payback via projected net income, where extreme values signal either overbought conditions or a critical collapse in earnings. When analyzing the forward price-to-earnings ratio of Liquidia Corporation (LQDA), investors must consider that high R&D expenses and the absence of stable revenue temporarily inflate this coefficient until the full commercial launch of the drugs.

Perusahaan pesaing

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|GLPG (Galapagos N.V.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi anipharmaceuticals.com ANIP|Rega marang bathi mangsa ngarep MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pacira BioSciences, Inc. PCRX|Pangali Forward P/E ARS Corp SPRY|Theravance Biopharma - Pangali Forward P/E|Pangali forward rega marang bathi Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep SXTC (China SXT Pharmaceuticals)|Pangali Forward P/E EPRX|Pangali Forward P/E bioharvest.com (BHST)|Rega marang bathi mangsa ngarep Invizyne Technologies EXOZ|ORMP: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC BioPharma Inc. (ABVC) - Rega marang bathi mangsa ngarep|cumberlandpharma.com (CPIX) - Pangali Forward P/E|QNTM (Quantum BioPharma) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP